BFC Planning, Inc.’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

BFC Planning, Inc.’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$742	Hold	250	–	–	﹤0.01%	3207
2026 Q1	$775	Hold	250	–	–	﹤0.01%	2785
2025 Q4	$1K	Buy	250 +125	+100%	+$980	﹤0.01%	2793
2025 Q3	$1.55K	Buy	+125	New	+$1.91K	﹤0.01%	2538
2025 Q2	–	Sell	-125	Closed	-$3.7K	–	2696
2025 Q1	$3.7K	Hold	125	–	–	﹤0.01%	2125
2024 Q4	$4.06K	Buy	+125	New	+$5.07K	﹤0.01%	2074

Other funds holding CANF

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BFC Planning, Inc.'s CANF Position: Q2 2026 in Review

BFC Planning, Inc. held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q2 2026 at 250 shares worth $742. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

BFC Planning, Inc. first reported a position in CANF in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.06K in Q4 2024. 9 funds tracked by Wall St. Rank hold CANF as of Q2 2026.

BFC Planning, Inc. held 250 shares of Can-Fite BioPharma American Depositary Shares worth $742 as of Q2 2026.
BFC Planning, Inc. left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q2 2026.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #3207 holding.
BFC Planning, Inc. first reported a position in Can-Fite BioPharma American Depositary Shares in Q4 2024 and has held it in 6 quarters since.
BFC Planning, Inc.'s Can-Fite BioPharma American Depositary Shares position peaked at $4.06K in Q4 2024.
9 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.